The dearth of antibiotic development (AAC ed.)

<p>Why are we running out of antibiotics? A look at the pharmaceutical development of one of the most life-saving class of drugs.</p> <p><strong>Topics discussed:</strong></p> <ul> <li>The reasons behind the stagnant and declining antibiotic development pipeline</li> <li>New initiatives focused on stimulating the antibiotic market</li> <li>Strategies to spur the antibiotic development</li> </ul> <p><strong>Guests:</strong></p> <ul> <li>Helen Boucher, MD. Professor of Medicine and Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Editor of AAC</li> <li>Karen Bush, PhD. Professor of Practice & Interim Director, Biotechnology Program<br /> Indiana University. Former Editor AAC.</li> </ul> <p>Visit <a href="https://aac.asm.org" target="_blank" rel= "noopener">aac.asm.org</a> to read current and archived issues of the Antimicrobial Agents and Chemotherapy journal.</p>